Enzyme Replacement Therapy Market Size - Global Industry, Share, Analysis, Trends and Forecast 2023 - 2032
CHAPTER 1. Industry Overview of Enzyme Replacement Therapy Market
1.1. Definition and Scope
1.1.1. Definition of Enzyme Replacement Therapy
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Enzyme Replacement Therapy Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Enzyme Replacement Therapy Market By Enzyme Type
1.2.3. Enzyme Replacement Therapy Market By Indication
1.2.4. Enzyme Replacement Therapy Market By End-user
1.2.5. Enzyme Replacement Therapy Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Enzyme Type
2.2.1. Secondary Enzyme Type
2.2.2. Primary Enzyme Type
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Enzyme Replacement Therapy Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Enzyme Replacement Therapy Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Price Trend of Key Raw Material
3.8.1. Raw Material Suppliers
3.8.2. Proportion of Manufacturing Cost Structure
3.8.2.1. Raw Material
3.8.2.2. Labor Cost
3.8.2.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2022
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2022
4.2. R&D Status of Major Manufacturers in 2022
CHAPTER 5. Enzyme Replacement Therapy Market By Enzyme Type
5.1. Introduction
5.2. Enzyme Replacement Therapy Revenue By Enzyme Type
5.2.1. Enzyme Replacement Therapy Revenue (USD Billion) and Forecast, By Enzyme Type, 2020-2032
5.2.2. Agalsidase Beta
5.2.2.1. Agalsidase Beta Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.3. Taliglucerase
5.2.3.1. Taliglucerase Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.4. Velaglucerase Alfa
5.2.4.1. Velaglucerase Alfa Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.5. Idursulfase
5.2.5.1. Idursulfase Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.6. Imiglucerase
5.2.6.1. Imiglucerase Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.7. Alglucosidase Alfa
5.2.7.1. Alglucosidase Alfa Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.8. Pegademase
5.2.8.1. Pegademase Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.9. Laronidase
5.2.9.1. Laronidase Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.10. Galsulfase
5.2.10.1. Galsulfase Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.11. Others
5.2.11.1. OthersMarket Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 6. Enzyme Replacement Therapy Market By Indication
6.1. Introduction
6.2. Enzyme Replacement Therapy Revenue By Indication
6.2.1. Enzyme Replacement Therapy Revenue (USD Billion) and Forecast, By Indication, 2020-2032
6.2.2. Fabry Disease
6.2.2.1. Fabry DiseaseMarket Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3. Pompe Disease
6.2.3.1. Pompe Disease Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.4. Gaucher Disease
6.2.4.1. Gaucher Disease Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.5. Scheie Syndrome
6.2.5.1. Scheie Syndrome Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.6. Maroteaux-Lamy Syndrome
6.2.6.1. Maroteaux-Lamy Syndrome Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.7. Hunter Disease
6.2.7.1. Hunter DiseaseMarket Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.8. Others
6.2.8.1. OthersMarket Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 7. Enzyme Replacement Therapy Market By End-user
7.1. Introduction
7.2. Enzyme Replacement Therapy Revenue By End-user
7.2.1. Enzyme Replacement Therapy Revenue (USD Billion) and Forecast, By End-user, 2020-2032
7.2.2. Hospitals
7.2.2.1. HospitalsMarket Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.3. Home care setting
7.2.3.1. Home care setting market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.4. Clinics
7.2.4.1. ClinicsMarket Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 8. North America Enzyme Replacement Therapy Market By Country
8.1. North America Enzyme Replacement Therapy Market Overview
8.2. U.S.
8.2.1. U.S. Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Enzyme Type, 2020-2032
8.2.2. U.S. Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Indication, 2020-2032
8.2.3. U.S. Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By End-user, 2020-2032
8.3. Canada
8.3.1. Canada Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Enzyme Type, 2020-2032
8.3.2. Canada Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Indication, 2020-2032
8.3.3. Canada Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By End-user, 2020-2032
8.4. North America PEST Analysis
CHAPTER 9. Europe Enzyme Replacement Therapy Market By Country
9.1. Europe Enzyme Replacement Therapy Market Overview
9.2. U.K.
9.2.1. U.K. Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Enzyme Type, 2020-2032
9.2.2. U.K. Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Indication, 2020-2032
9.2.3. U.K. Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By End-user, 2020-2032
9.3. Germany
9.3.1. Germany Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Enzyme Type, 2020-2032
9.3.2. Germany Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Indication, 2020-2032
9.3.3. Germany Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By End-user, 2020-2032
9.4. France
9.4.1. France Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Enzyme Type, 2020-2032
9.4.2. France Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Indication, 2020-2032
9.4.3. France Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By End-user, 2020-2032
9.5. Spain
9.5.1. Spain Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Enzyme Type, 2020-2032
9.5.2. Spain Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Indication, 2020-2032
9.5.3. Spain Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By End-user, 2020-2032
9.6. Rest of Europe
9.6.1. Rest of Europe Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Enzyme Type, 2020-2032
9.6.2. Rest of Europe Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Indication, 2020-2032
9.6.3. Rest of Europe Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By End-user, 2020-2032
9.7. Europe PEST Analysis
CHAPTER 10. Asia Pacific Enzyme Replacement Therapy Market By Country
10.1. Asia Pacific Enzyme Replacement Therapy Market Overview
10.2. China
10.2.1. China Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Enzyme Type, 2020-2032
10.2.2. China Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Indication, 2020-2032
10.2.3. China Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By End-user, 2020-2032
10.3. Japan
10.3.1. Japan Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Enzyme Type, 2020-2032
10.3.2. Japan Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Indication, 2020-2032
10.3.3. Japan Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By End-user, 2020-2032
10.4. India
10.4.1. India Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Enzyme Type, 2020-2032
10.4.2. India Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Indication, 2020-2032
10.4.3. India Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By End-user, 2020-2032
10.5. Australia
10.5.1. Australia Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Enzyme Type, 2020-2032
10.5.2. Australia Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Indication, 2020-2032
10.5.3. Australia Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By End-user, 2020-2032
10.6. South Korea
10.6.1. South Korea Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Enzyme Type, 2020-2032
10.6.2. South Korea Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Indication, 2020-2032
10.6.3. South Korea Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By End-user, 2020-2032
10.7. Rest of Asia-Pacific
10.7.1. Rest of Asia-Pacific Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Enzyme Type, 2020-2032
10.7.2. Rest of Asia-Pacific Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Indication, 2020-2032
10.7.3. Rest of Asia-Pacific Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By End-user, 2020-2032
10.8. Asia Pacific PEST Analysis
CHAPTER 11. Latin America Enzyme Replacement Therapy Market By Country
11.1. Latin America Enzyme Replacement Therapy Market Overview
11.2. Brazil
11.2.1. Brazil Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Enzyme Type, 2020-2032
11.2.2. Brazil Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Indication, 2020-2032
11.2.3. Brazil Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By End-user, 2020-2032
11.3. Mexico
11.3.1. Mexico Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Enzyme Type, 2020-2032
11.3.2. Mexico Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Indication, 2020-2032
11.3.3. Mexico Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By End-user, 2020-2032
11.4. Rest of Latin America
11.4.1. Rest of Latin America Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Enzyme Type, 2020-2032
11.4.2. Rest of Latin America Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Indication, 2020-2032
11.4.3. Rest of Latin America Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By End-user, 2020-2032
11.5. Latin America PEST Analysis
CHAPTER 12. Middle East & Africa Enzyme Replacement Therapy Market By Country
12.1. Middle East & Africa Enzyme Replacement Therapy Market Overview
12.2. GCC
12.2.1. GCC Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Enzyme Type, 2020-2032
12.2.2. GCC Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Indication, 2020-2032
12.2.3. GCC Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By End-user, 2020-2032
12.3. South Africa
12.3.1. South Africa Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Enzyme Type, 2020-2032
12.3.2. South Africa Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Indication, 2020-2032
12.3.3. South Africa Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By End-user, 2020-2032
12.4. Rest of Middle East & Africa
12.4.1. Rest of Middle East & Africa Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Enzyme Type, 2020-2032
12.4.2. Rest of Middle East & Africa Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Indication, 2020-2032
12.4.3. Rest of Middle East & Africa Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By End-user, 2020-2032
12.5. Middle East & Africa PEST Analysis
CHAPTER 13. Player Analysis Of Enzyme Replacement Therapy Market
13.1. Enzyme Replacement Therapy MarketCompany Share Analysis
13.2. Competition Matrix
13.2.1. Competitive Benchmarking Of Key Players By Price, Presence, Market Share, And R&D Investment
13.2.2. New ProductLaunches and Product Enhancements
13.2.3. Mergers And Acquisition InGlobal Enzyme Replacement Therapy Market
13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 14. Company Profile
14.1. Sanofi Genzyme
14.1.1. Company Snapshot
14.1.2. Business Overview
14.1.3. Financial Overview
14.1.3.1. Revenue (USD Billion), 2022
14.1.3.2. Sanofi Genzyme 2022 Enzyme Replacement Therapy Business Regional Distribution
14.1.4. Product /Service and Specification
14.1.5. Recent Developments & Business Strategy
14.2. Shire (part of Takeda Pharmaceuticals)
14.3. BioMarin Pharmaceutical Inc.
14.4. Alexion Pharmaceuticals
14.5. Pfizer Inc.
14.6. AbbVie Inc.
14.7. Amicus Therapeutics
14.8. JCR Pharmaceuticals Co., Ltd.
14.9. Protalix Biotherapeutics, Inc.
14.10. Sangamo Therapeutics, Inc.
Frequently Asked Questions
What was the market size of the global enzyme replacement therapy in 2022?
The market size of enzyme replacement therapy was USD 10.1 Billion in 2022.
What is the CAGR of the global enzyme replacement therapy market from 2023 to 2032?
The CAGR of enzyme replacement therapy is 7.6% during the analysis period of 2023 to 2032.
Which are the key players in the enzyme replacement therapy market?
The key players operating in the global market are including Sanofi Genzyme, Shire (part of Takeda Pharmaceuticals), BioMarin Pharmaceutical Inc., Alexion Pharmaceuticals, Pfizer Inc., AbbVie Inc., Amicus Therapeutics, JCR Pharmaceuticals Co., Ltd., Protalix Biotherapeutics, Inc., and Sangamo Therapeutics, Inc.
Which region dominated the global enzyme replacement therapy market share?
North America held the dominating position in enzyme replacement therapy industry during the analysis period of 2023 to 2032.
Which region registered fastest CAGR from 2023 to 2032?
Asia-Pacific region exhibited fastest growing CAGR for market of enzyme replacement therapy during the analysis period of 2023 to 2032.
What are the current trends and dynamics in the global enzyme replacement therapy industry?
The current trends and dynamics in the enzyme replacement therapy industry include increasing incidence of rare genetic disorders, rising demand for effective treatment options, and growing awareness of rare genetic diseases.
Which Indication held the maximum share in 2022?
The gaucher disease indication held the maximum share of the enzyme replacement therapy industry.
Select Licence Type
Connect with our sales team
Why Acumen Research and Consulting
100%
Customer Satisfaction
24x7+
Availability - we are always there when you need us
200+
Fortune 50 Companies trust Acumen Research and Consulting
80%
of our reports are exclusive and first in the industry
100%
more data and analysis
1000+
reports published till date
